Rating History for 6/29/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals
(Canaccord - Sumant Kulkami) |
ACAD | Maintain | Buy (N/A) |
36.00 (32.00) |
|
Details | |||
| Acadia Pharmaceuticals
(Deutsche Bank - David Hoang) |
ACAD | Maintain | Buy (N/A) |
37.00 (32.00) |
|
Details | |||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 359 more... | |||||||||
